[Benign drug jaundice during treatment combining rifampicin and triacetyloleandomycin].
D000368:Aged; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007565:Jaundice / Q000139:chemically induced*; D012293:Rifampin / Q000009:adverse effects*; D014217:Troleandomycin / Q000009:adverse effects*
D014217:Troleandomycin; D012293:Rifampin
Ictère bénin médicamenteux lors d'un traitement associant rifampicine-triacétyloléandomycine.